ORION ENERGY SYSTEMS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ORION ENERGY SYSTEMS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $79.72M | Jun 26, 2025 |
| FY2024 | Mar 31, 2024 | $26.41M | Jun 12, 2024 |
| FY2024 | Dec 31, 2023 | $25.97M | Jun 12, 2024 |
| FY2024 | Sep 30, 2023 | $20.59M | Jun 12, 2024 |
| FY2024 | Jun 30, 2023 | $17.61M | Jun 12, 2024 |
| FY2024 | Mar 31, 2023 | $21.63M | Jun 12, 2024 |
| FY2024 | Dec 31, 2022 | $20.29M | Jun 12, 2024 |
| FY2024 | Sep 30, 2022 | $17.56M | Jun 12, 2024 |
| FY2024 | Jun 30, 2022 | $17.91M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | $22.06M | Jun 12, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $20.24M | Jun 26, 2025 |
| FY2024 | Mar 31, 2024 | $6.80M | Jun 12, 2024 |
| FY2024 | Dec 31, 2023 | $6.37M | Jun 12, 2024 |
| FY2024 | Sep 30, 2023 | $4.57M | Jun 12, 2024 |
| FY2024 | Jun 30, 2023 | $3.17M | Jun 12, 2024 |
| FY2024 | Mar 31, 2023 | $4.74M | Jun 12, 2024 |
| FY2024 | Dec 31, 2022 | $4.78M | Jun 12, 2024 |
| FY2024 | Sep 30, 2022 | $4.44M | Jun 12, 2024 |
| FY2024 | Jun 30, 2022 | $3.55M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | $5.25M | Jun 12, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($11.80M) | Jun 26, 2025 |
| FY2024 | Mar 31, 2024 | $1.61M | Jun 12, 2024 |
| FY2024 | Dec 31, 2023 | ($2.26M) | Jun 12, 2024 |
| FY2024 | Sep 30, 2023 | ($4.39M) | Jun 12, 2024 |
| FY2024 | Jun 30, 2023 | ($6.64M) | Jun 12, 2024 |
| FY2024 | Mar 31, 2023 | ($5.12M) | Jun 12, 2024 |
| FY2024 | Dec 31, 2022 | ($24.06M) | Jun 12, 2024 |
| FY2024 | Sep 30, 2022 | ($2.33M) | Jun 12, 2024 |
| FY2024 | Jun 30, 2022 | ($2.84M) | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | ($1.18M) | Jun 12, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($10.60M) | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | ($10.82M) | Jun 26, 2025 |
| FY2025 | Mar 31, 2023 | ($15.99M) | Jun 26, 2025 |
| FY2024 | Mar 31, 2022 | $8.39M | Jun 12, 2024 |
| FY2023 | Mar 31, 2021 | $6.84M | Jun 12, 2023 |
| FY2022 | Mar 31, 2020 | $13.11M | Jun 10, 2022 |
| FY2021 | Mar 31, 2019 | ($6.16M) | Jun 1, 2021 |
| FY2020 | Mar 31, 2018 | ($12.98M) | Jun 5, 2020 |
| FY2019 | Mar 31, 2017 | ($12.53M) | Jun 5, 2019 |
| FY2018 | Mar 31, 2016 | ($19.92M) | Jun 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.23M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $1.50M | Jun 26, 2025 |
| FY2025 | Mar 31, 2023 | $1.85M | Jun 26, 2025 |
| FY2024 | Mar 31, 2022 | $1.70M | Jun 12, 2024 |
| FY2023 | Mar 31, 2021 | $1.69M | Jun 12, 2023 |
| FY2022 | Mar 31, 2020 | $1.72M | Jun 10, 2022 |
| FY2021 | Mar 31, 2019 | $1.37M | Jun 1, 2021 |
| FY2020 | Mar 31, 2018 | $1.91M | Jun 5, 2020 |
| FY2019 | Mar 31, 2017 | $2.00M | Jun 5, 2019 |
| FY2018 | Mar 31, 2016 | $1.67M | Jun 13, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $599.0K | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | ($10.09M) | Jun 26, 2025 |
| FY2025 | Mar 31, 2023 | ($2.29M) | Jun 26, 2025 |
| FY2024 | Mar 31, 2022 | ($113.0K) | Jun 12, 2024 |
| FY2023 | Mar 31, 2021 | $1.73M | Jun 12, 2023 |
| FY2022 | Mar 31, 2020 | $20.34M | Jun 10, 2022 |
| FY2021 | Mar 31, 2019 | ($5.06M) | Jun 1, 2021 |
| FY2020 | Mar 31, 2018 | ($4.42M) | Jun 5, 2020 |
| FY2019 | Mar 31, 2017 | ($1.90M) | Jun 5, 2019 |
| FY2018 | Mar 31, 2016 | ($3.47M) | Jun 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $99.0K | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $837.0K | Jun 26, 2025 |
| FY2025 | Mar 31, 2023 | $586.0K | Jun 26, 2025 |
| FY2024 | Mar 31, 2022 | $518.0K | Jun 12, 2024 |
| FY2023 | Mar 31, 2021 | $902.0K | Jun 12, 2023 |
| FY2022 | Mar 31, 2020 | $814.0K | Jun 10, 2022 |
| FY2021 | Mar 31, 2019 | $381.0K | Jun 1, 2021 |
| FY2020 | Mar 31, 2018 | $512.0K | Jun 5, 2020 |
| FY2019 | Mar 31, 2017 | $660.0K | Jun 5, 2019 |
| FY2018 | Mar 31, 2016 | $401.0K | Jun 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $52.46M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $63.17M | Jun 26, 2025 |
| FY2024 | Mar 31, 2023 | $71.58M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | $86.82M | Jun 12, 2023 |
| FY2022 | Mar 31, 2021 | $92.82M | Jun 10, 2022 |
| FY2021 | Mar 31, 2020 | $72.56M | Jun 1, 2021 |
| FY2020 | Mar 31, 2019 | $56.02M | Jun 5, 2020 |
| FY2019 | Mar 31, 2018 | $45.33M | Jun 5, 2019 |
| FY2018 | Mar 31, 2017 | $62.05M | Jun 13, 2018 |
| FY2017 | Mar 31, 2016 | $70.88M | Jun 13, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $40.58M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $40.63M | Jun 26, 2025 |
| FY2024 | Mar 31, 2023 | $38.33M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | $21.72M | Jun 12, 2023 |
| FY2022 | Mar 31, 2021 | $34.75M | Jun 10, 2022 |
| FY2021 | Mar 31, 2020 | $41.53M | Jun 1, 2021 |
| FY2020 | Mar 31, 2019 | $38.05M | Jun 5, 2020 |
| FY2019 | Mar 31, 2018 | $21.90M | Jun 5, 2019 |
| FY2018 | Mar 31, 2017 | $26.60M | Jun 13, 2018 |
| FY2017 | Mar 31, 2016 | $24.89M | Jun 13, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $11.88M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $22.54M | Jun 26, 2025 |
| FY2025 | Mar 31, 2023 | $33.25M | Jun 26, 2025 |
| FY2025 | Mar 31, 2022 | $65.10M | Jun 26, 2025 |
| FY2024 | Mar 31, 2021 | $58.07M | Jun 12, 2024 |
| FY2023 | Mar 31, 2020 | $31.04M | Jun 12, 2023 |
| FY2022 | Mar 31, 2019 | $17.97M | Jun 10, 2022 |
| FY2021 | Mar 31, 2018 | $23.42M | Jun 1, 2021 |
| FY2020 | Mar 31, 2017 | $35.45M | Jun 5, 2020 |
| FY2019 | Mar 31, 2016 | $45.98M | Jun 5, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.48M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $1.48M | Jun 26, 2025 |
| FY2024 | Mar 31, 2023 | $1.48M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | $350.0K | Jun 12, 2023 |
| FY2018 | Mar 31, 2018 | $0 | Jun 13, 2018 |
| FY2018 | Mar 31, 2017 | $0 | Jun 13, 2018 |
| FY2017 | Mar 31, 2016 | $0 | Jun 13, 2017 |
| FY2017 | Mar 31, 2015 | $4.41M | Jun 13, 2017 |
| FY2016 | Mar 31, 2014 | $4.41M | Jun 23, 2016 |
| FY2014 | Mar 31, 2013 | $0 | Jun 12, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($114.89M) | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | ($103.09M) | Jun 26, 2025 |
| FY2024 | Mar 31, 2023 | ($91.42M) | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | ($57.08M) | Jun 12, 2023 |
| FY2022 | Mar 31, 2021 | ($63.17M) | Jun 10, 2022 |
| FY2021 | Mar 31, 2020 | ($89.31M) | Jun 1, 2021 |
| FY2020 | Mar 31, 2019 | ($101.77M) | Jun 5, 2020 |
| FY2019 | Mar 31, 2018 | ($95.49M) | Jun 5, 2019 |
| FY2018 | Mar 31, 2017 | ($82.37M) | Jun 13, 2018 |
| FY2017 | Mar 31, 2016 | ($70.08M) | Jun 13, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.97M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $5.16M | Jun 26, 2025 |
| FY2024 | Mar 31, 2023 | $15.99M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | $14.47M | Jun 12, 2023 |
| FY2022 | Mar 31, 2021 | $19.39M | Jun 10, 2022 |
| FY2021 | Mar 31, 2020 | $28.75M | Jun 1, 2021 |
| FY2020 | Mar 31, 2019 | $8.73M | Jun 5, 2020 |
| FY2019 | Mar 31, 2018 | $9.42M | Jun 5, 2019 |
| FY2019 | Mar 31, 2017 | $17.31M | Jun 5, 2019 |
| FY2019 | Mar 31, 2016 | $15.54M | Jun 5, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $10.32M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | $10.00M | Jun 26, 2025 |
| FY2024 | Mar 31, 2023 | $10.02M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | $35.0K | Jun 12, 2023 |
| FY2022 | Mar 31, 2021 | $49.0K | Jun 10, 2022 |
| FY2021 | Mar 31, 2020 | $10.10M | Jun 1, 2021 |
| FY2020 | Mar 31, 2019 | $9.38M | Jun 5, 2020 |
| FY2019 | Mar 31, 2018 | $4.09M | Jun 5, 2019 |
| FY2018 | Mar 31, 2017 | $6.97M | Jun 13, 2018 |
| FY2017 | Mar 31, 2016 | $4.77M | Jun 13, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 26, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Jun 12, 2024 |
| FY2024 | Dec 31, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Jun 12, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Jun 12, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jun 12, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 26, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Jun 12, 2024 |
| FY2024 | Dec 31, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Jun 12, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Jun 12, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Jun 12, 2024 |
| FY2024 | Jun 30, 2022 | 0 | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jun 12, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 32.98M | Jun 26, 2025 |
| FY2025 | Mar 31, 2024 | 32.57M | Jun 26, 2025 |
| FY2024 | Mar 31, 2023 | 32.30M | Jun 12, 2024 |
| FY2023 | Mar 31, 2022 | 31.10M | Jun 12, 2023 |
| FY2022 | Mar 31, 2021 | 30.81M | Jun 10, 2022 |
| FY2021 | Mar 31, 2020 | 30.27M | Jun 1, 2021 |
| FY2020 | Mar 31, 2019 | 29.60M | Jun 5, 2020 |
| FY2011 | Mar 31, 2012 | 22.79M | Jun 14, 2012 |
| FY2011 | Mar 31, 2011 | 22.89M | Jun 14, 2012 |